Coulter Partners places Chief Medical Officer at CARsgen Therapeutics to accelerate the global clinical development of their innovative product candidates
CN Bio announced the appointment of Dr Paul Brooks as Chief Business Officer. Key to the next stage of the Company’s growth, Paul will be responsible for shaping the company’s commercial business strategy and leading the expansion of its global commercial organisation.
Coulter Partners recently partnered with Treadwell Therapeutics, a clinical-stage biotechnology company developing novel, cross-modality medicines for unmet needs in cancer, and are pleased to announce the placement of J.D. Mowery as Chief Operating Officer (COO).
Leading Nuclear Magnetic Resonance (NMR) specialists QUAD Systems has selected Milton Park, an Oxfordshire-based business, science, and technology community, to be its first premises in the UK.
